Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

Gino Villetti, Marco Bergamaschi, Franco Bassani, Pier Tonino Bolzoni, Marisa Maiorino, Claudio Pietra, Ivano Rondelli, Philippe Chamiot-Clerc, Michele Simonato and Mario Barbieri
Journal of Pharmacology and Experimental Therapeutics August 2003, 306 (2) 804-814; DOI: https://doi.org/10.1124/jpet.103.050039
Gino Villetti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Bergamaschi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franco Bassani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pier Tonino Bolzoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisa Maiorino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Pietra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivano Rondelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Chamiot-Clerc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Simonato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Barbieri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 306 no. 2 804-814
DOI 
https://doi.org/10.1124/jpet.103.050039
PubMed 
12750440

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 4, 2003
  • Accepted May 2, 2003
  • Published online July 18, 2003.

Article Versions

  • Earlier version (May 15, 2003 - 13:52).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Gino Villetti,
  2. Marco Bergamaschi,
  3. Franco Bassani,
  4. Pier Tonino Bolzoni,
  5. Marisa Maiorino,
  6. Claudio Pietra,
  7. Ivano Rondelli,
  8. Philippe Chamiot-Clerc,
  9. Michele Simonato and
  10. Mario Barbieri
  1. Research and Development Department, Chiesi Farmaceutici S.p.A., Parma, Italy (G.V., M.B., F.B., P.T.B., M.M., C.P., I.R.); Cerep, Biology Department, Rueil-Malmaison Cedex, France (P.C.C.); and Department of Clinical and Experimental Medicine, Section of Pharmacology, and Neuroscience Center, University of Ferrara, Ferrara, Italy (M.S., M.B.)
  1. Address correspondence to:
    Dr. Gino Villetti, R & D Department, Chiesi Farmaceutici S.p.A., Via Palermo 26/A-43100, Parma, Italy. E-mail: g.villetti{at}chiesigroup.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2003 to June 2023

AbstractFullPdf
May 2003210106
Jun 200317090
Jul 20037244148
Aug 2003475085
Sep 2003409193
Oct 2003238972
Nov 2003356350
Dec 2003214236
Jan 2004389263
Feb 2004215046
Mar 2004386348
Apr 2004216642
May 2004336134
Jun 2004365828
Jul 2004356528
Aug 2004465158
Sep 2004245635
Oct 2004275444
Nov 2004217756
Dec 2004175132
Jan 2005185952
Feb 2005187853
Mar 2005165645
Apr 200573525
May 2005125741
Jun 2005115134
Jul 2005133734
Aug 200573729
Sep 2005114225
Oct 2005104336
Nov 2005105337
Dec 200554834
Jan 2006125027
Feb 2006134222
Mar 200634434
Apr 200653525
May 200653928
Jun 200653617
Jul 2006133233
Aug 200653528
Sep 200653024
Oct 200643633
Nov 200683832
Dec 200643716
Jan 2007102125
Feb 200792224
Mar 200771921
Apr 200792831
May 200753220
Jun 2007112741
Jul 200753043
Aug 200732618
Sep 200723515
Oct 200783334
Nov 200762217
Dec 200722821
Jan 200852126
Feb 2008102416
Mar 200842311
Apr 200863321
May 2008192127
Jun 200863430
Jul 200893033
Aug 20081297
Sep 2008101923
Oct 2008181711
Nov 2008132121
Dec 200883023
Jan 2009144222
Feb 200922520
Mar 2009162219
Apr 2009172029
May 2009102920
Jun 200961818
Jul 200961918
Aug 20092149
Sep 200982213
Oct 2009101514
Nov 200932018
Dec 200911311
Jan 2010122017
Feb 2010132218
Mar 2010131812
Apr 201081910
May 2010131612
Jun 2010162118
Jul 201071617
Aug 2010141621
Sep 2010131217
Oct 2010122413
Nov 2010122322
Dec 2010131611
Jan 2011151011
Feb 2011171916
Mar 2011152723
Apr 2011221820
May 2011152518
Jun 2011112213
Jul 2011212529
Aug 2011181625
Sep 2011112623
Oct 2011212516
Nov 2011143526
Dec 2011182918
Jan 2012153225
Feb 2012142226
Mar 2012182116
Apr 2012131417
May 2012131616
Jun 2012181212
Jul 2012142514
Aug 2012122217
Sep 2012181922
Oct 2012201917
Nov 2012142222
Dec 2012162313
Jan 2013162016
Feb 2013142311
Mar 2013172519
Apr 2013191917
May 2013132113
Jun 2013101410
Jul 20136139
Aug 20137115
Sep 2013141115
Oct 20133157
Nov 2013112015
Dec 20133186
Jan 2014102812
Feb 20145105
Mar 201412910
Apr 201442110
May 20148148
Jun 201416914
Jul 201418296
Aug 20144710
Sep 2014141516
Oct 2014589
Nov 2014277
Dec 20141088
Jan 2015191413
Feb 201510136
Mar 201561110
Apr 20154149
May 20158105
Jun 20157514
Jul 201571516
Aug 2015975
Sep 2015171111
Oct 201526195
Nov 2015694
Dec 2015121713
Jan 20161599
Feb 20167610
Mar 20168410
Apr 20160614
May 201691716
Jun 201612718
Jul 2016121224
Aug 2016111122
Sep 201674017
Oct 20160474
Nov 201656914
Dec 20160945
Jan 201725313
Feb 201725613
Mar 20172647
Apr 20170452
May 20170184
Jun 20170140
Jul 20173118
Aug 20172162
Sep 20171134
Oct 20172127
Nov 20174259
Dec 20171178
Jan 201801817
Feb 201831112
Mar 201811410
Apr 201811710
May 201821911
Jun 20181175
Jul 20180111
Aug 20183186
Sep 2018154
Oct 20182187
Nov 201863310
Dec 20182573
Jan 20194301
Feb 20193807
Mar 20191311
Apr 20191200
May 20191519
Jun 20192213
Jul 20191400
Aug 20192702
Sep 20192600
Oct 20191221
Nov 20192205
Dec 20191711
Jan 20201301
Feb 2020610
Mar 20201000
Apr 2020511
May 2020210
Jun 20201700
Jul 20201201
Aug 2020101
Sep 20201420
Oct 20201713
Nov 20201111
Dec 20201011
Jan 20211654
Feb 20211714
Mar 20211922
Apr 20211622
May 20211531
Jun 2021722
Jul 20211315
Aug 20211011
Sep 2021720
Oct 2021731
Nov 20211321
Dec 20212021
Jan 20221706
Feb 2022521
Mar 20221232
Apr 20221626
May 2022611
Jun 20221210
Jul 20221821
Aug 20222225
Sep 20221614
Oct 2022620
Nov 2022610
Dec 2022610
Jan 20231413
Feb 20231110
Mar 2023701
Apr 2023521
May 20231414
Jun 2023221

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 306 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 306, Issue 2
1 Aug 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

Gino Villetti, Marco Bergamaschi, Franco Bassani, Pier Tonino Bolzoni, Marisa Maiorino, Claudio Pietra, Ivano Rondelli, Philippe Chamiot-Clerc, Michele Simonato and Mario Barbieri
Journal of Pharmacology and Experimental Therapeutics August 1, 2003, 306 (2) 804-814; DOI: https://doi.org/10.1124/jpet.103.050039

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

Gino Villetti, Marco Bergamaschi, Franco Bassani, Pier Tonino Bolzoni, Marisa Maiorino, Claudio Pietra, Ivano Rondelli, Philippe Chamiot-Clerc, Michele Simonato and Mario Barbieri
Journal of Pharmacology and Experimental Therapeutics August 1, 2003, 306 (2) 804-814; DOI: https://doi.org/10.1124/jpet.103.050039
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • VTA Muscarinic M5 Receptors and Effort-Choice Behavior
  • Substituted Tryptamine Activity at 5-HT Receptors and SERT
  • KRM-II-81 Analogs
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics